Abstract: A coupling clamp is provided that includes a top clamp and a bottom clamp. The top clamp may include a top vertical flange and a top lateral flange. The bottom clamp may include a bottom vertical flange and one or more bottom lateral flanges that extend laterally in opposite directions. At least one of the bottom lateral flanges may include a first portion having a surface configured to engage with a solar module and a second portion connected to the bottom vertical flange at an intersection below the surface of the first portion. The coupling clamp may be installed onto one or more solar modules that are positioned onto a rail that has an installed rail clamp. Another solar module may be positioned on the coupling clamp and rail and then slid under the rail clamp, which may be tightened to secure the other solar module to the rail.

Abstract: Systems and methods for analyzing physical characteristics of a battery include arrangements of two or more transducers coupled to the battery. A control module controls one or more of the two or more transducers to transmit acoustic signals through at least a portion of the battery, and one or more of the two or more transducers to receive response acoustic signals. Distribution of physical properties of the battery is determined based at least on the transmitted acoustic signals and the response acoustic signals.

Abstract: A splice having a main body and one or more protrusions extending from the main body. The one or more protrusions can be operable to interfere with a rail when the main body is installed into an opening of the rail. The one or more protrusions may be operable to cut into a coating of the rail and form an electrical connection between the rail and the main body.

Abstract: A solar mount, for use with a bracket attachment, has an open and a closed state. In the open state, grip flanges on two hinged arms can pass through a slot opening on the bracket attachment. In the closed state, the grip flanges cooperate with respective groves in the bracket attachment to secure the solar mount to the bracket attachment. In the closed state, a fastener attaches a solar accessory, such as a rail, and holds the two hinged arms together. A flexible mount helps hold the two hinged arms together in the open state, and also helps hold the two hinged arms in the closed state.

Abstract: A splice having a main body and one or more protrusions extending from the main body. The one or more protrusions can be operable to interfere with a rail when the main body is installed into an opening of the rail. The one or more protrusions may be operable to cut into a coating of the rail and form an electrical connection between the rail and the main body.

Abstract: Disclosed herein, inter alia, are compounds and methods for inhibiting Taspase1 and the treatment of cancer.

Abstract: Aspects of the disclosure relate to methods, systems, computer-readable storage media, and graphical user interfaces (GUIs) that are useful for characterizing subjects having certain cancers, for example renal cell carcinomas such as clear cell renal carcinoma (ccRCC). The disclosure is based, in part, on methods for determining the renal cancer (RC) tumor microenvironment (TME) type (RC TME type) of a renal cancer subject and the subject's prognosis and/or likelihood of responding to certain therapies (e.g., immunotherapy or tyrosine kinase inhibitors) based upon the renal cancer type determination.

Abstract: A splice having a main body and one or more protrusions extending from the main body. The one or more protrusions can be operable to interfere with a rail when the main body is installed into an opening of the rail. The one or more protrusions may be operable to cut into a coating of the rail and form an electrical connection between the rail and the main body.

Abstract: A u-shaped clamp that includes offset bends at distal ends, accepts a threaded fastener through two apertures, where tightening the fastener brings two flanges of the u-shaped clamp together to grip a wire, a cable or a pipe. An offset bend on one end of one flange serves to hold a wire or cable in position until the fastener is tightened.

Abstract: A solar mount, for use with a bracket attachment, has an open and a closed state. In the open state, grip flanges on two hinged arms can pass through a slot opening on the bracket attachment. In the closed state, the grip flanges cooperate with respective groves in the bracket attachment to secure the solar mount to the bracket attachment. In the closed state, a fastener attaches a solar accessory, such as a rail, and holds the two hinged arms together. A flexible mount helps hold the two hinged arms together in the open state, and also helps hold the two hinged arms in the closed state.

Abstract: A splice having a main body and one or more protrusions extending from the main body. The one or more protrusions can be operable to interfere with a rail when the main body is installed into an opening of the rail. The one or more protrusions may be operable to cut into a coating of the rail and form an electrical connection between the rail and the main body.

Abstract: An electrically conductive bond jumper connects two solar modules, and is affixed to the solar modules with u-shaped spring grips on each end. The spring grips have sharp pointed teeth to penetrate coatings on the solar modules and enhance the electrical connection between the solar modules.

Abstract: A clamp particularly designed for use on the end of a solar module mounting rail, includes two hinged parts that can be adjusted by a fastener to clamp a solar module to the rail. A pull-tab with toothed catches helps to position the clamp during installation, and also prevents the clamp from sliding too far into the rail, while a grip body increases friction and electrical contact between the solar module and the clamp.

Abstract: Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.

Abstract: A twist-lock clamp to attach a solar module to a rail system includes a spring between a top clamp and a t-nut, with features on the spring and top clamp to restrict rotation relative to each other. The t-nut includes features allowing rotation of about 90 degrees when the t-nut is inserted in a rail, but restrict rotation beyond about 90 degrees. The spring serves to hold the top clamp and t-nut apart while allowing the twist-lock clamp to resist sliding in the rail during installation.

Abstract: A splice having a main body and one or more protrusions extending from the main body. The one or more protrusions can be operable to interfere with a rail when the main body is installed into an opening of the rail. The one or more protrusions may be operable to cut into a coating of the rail and form an electrical connection between the rail and the main body.

Abstract: Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.

Abstract: A method of identifying inhibitors of the anti-apoptotic survival pathway in cancer cells is disclosed. The method comprises the steps of (a) exposing cultured wild-type cells to a candidate inhibitor at a predetermined concentratioh for a predetermined period of time and determining cell viability aftet the exposure to the candidate inhibitor; (b) exposing two or more cell lines of specifically MCL-1 or BCL-2 or BCL-X1 addicted cells to the candidate inhibitor at the predetermined concentration for the predetermined period of time and determining cell viability after the exposure to the candidate inhibitor, and (c) indentifying the candidate inhibitor as a MCL-1 or BCL-2 or BCL-X1 inhibitor if the cell viability in step (a) is significantly higher than the cell viability in step (b). The disclosed method provides a way to identify inhibitors which selectively inhibit specific members of the BCL-2 family (e.g.

Abstract: Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.

Abstract: Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.